The present study systematically reviews the literature on the effectiveness of the LH‐RH agonist triptorelin in PCa patients with LUTS, addressing the need to alleviate urinary symptoms and improve patient QoL in this specific population. Here, GNRH1 is linked to posterior cortical atrophy.